Breaking News Instant updates and real-time market news.

CLIR

ClearSign Combustion

$3.60

-0.1 (-2.70%)

, CTIC

CTI BioPharma

$3.39

0.04 (1.19%)

17:49
07/13/17
07/13
17:49
07/13/17
17:49

On The Fly: After Hours Movers

HIGHER: ClearSign Combusion (CLIR), up 16.7% after it received a purchase order from a supermajor oil company to qualify its Duplex combustion technology... CTI BioPharma (CTIC), up 11.8% after its Marketing Authorization Application for pacritinib was validated by the European Medicines Agency... Celadon Group (CGI), up 10.6% after it named Paul Svindland to succeed Paul Will as chief executive officer... Sangamo (SGMO), up 4.7% after its MPS candidates were granted Fast Track designation by the FDA... Mylan (MYL), up 2.2% after it said that the FDA's Oncologic Drugs Advisorty Committee recommended the approval of Mylan and Biocon's proposed biosimilar trastuzumab. LOWER: CyberArk (CYBR), down 18.2% after it cut its revneue guidance for Q2 due to its performance in EMEA... A10 Netorks (ATEN), down 17% after it lowered its guidance for Q2, saying a number of opportunities in its pipeline did not close primarily in North America and to a lesser degree in Japan.

CLIR

ClearSign Combustion

$3.60

-0.1 (-2.70%)

CTIC

CTI BioPharma

$3.39

0.04 (1.19%)

CGI

Celadon Group

$2.35

-0.05 (-2.08%)

SGMO

Sangamo

$9.50

0.25 (2.70%)

MYL

Mylan

$39.05

0.47 (1.22%)

CYBR

CyberArk

$51.00

0.56 (1.11%)

ATEN

A10 Networks

$8.24

0.03 (0.37%)

  • 13

    Jul

  • 13

    Jul

  • 08

    Aug

  • 08

    Aug

  • 03

    Sep

  • 09

    Oct

CLIR ClearSign Combustion
$3.60

-0.1 (-2.70%)

CTIC CTI BioPharma
$3.39

0.04 (1.19%)

CGI Celadon Group
$2.35

-0.05 (-2.08%)

04/06/17
AGIS
04/06/17
NO CHANGE
Target $15
AGIS
Buy
Aegis says Celadon short report concerns 'largely repackaged and republished'
Aegis analyst Jeffrey Kauffman said some of the concerns raised in the short report published on Celadon Group yesterday are "interesting and thought provoking," but he also views them as "largely repackaged and republished" from similar reports from 2016. Some of reports' assertions are factually accurate, but they are used in a distorted ways to arrive at a factually inaccurate conclusion, said the analyst , who views the pullback yesterday as a buying opportunity. Kauffman keeps a Buy rating and $15 price target on Celadon shares, which slid nearly 15% following Prescience Point Research's report.
01/12/17
01/12/17
UPGRADE
Target $11

Buy
Celadon Group upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Rhem Wood upgraded Celadon Group to Buy from Neutral with an $11 price target saying the joint-venture spinoff allows the company to refocus on its core trucking business. Despite a lot of noise in the investor community recently, Wood believes the negatives have been overstated, and earnings are currently at the trough with substantial upside from here.
02/10/17
STFL
02/10/17
UPGRADE
Target $10
STFL
Hold
Celadon Group upgraded to Hold from Sell at Stifel
Stifel analyst John Larkin upgraded Celadon Group to Hold with a $10 price target. The analyst said Truckload sector expectations have come down materially across the Street and believes we are now entering a more constructive period of investing as economic improvement could benefit freight volumes.
03/02/17
AGIS
03/02/17
INITIATION
Target $15
AGIS
Buy
Celadon Group initiated with a Buy at Aegis
Aegis analyst Jeffrey Kauffman initiated Celadon Group with a Buy and a $15 price target saying it trades at a 36% discount to its book value and is one of a few trucking equities that remain undervalued because of a lack of following and concerns about factors that have been largely alleviated.
SGMO Sangamo
$9.50

0.25 (2.70%)

09/06/16
WELS
09/06/16
NO CHANGE
WELS
Outperform
Wells calls Sangamo an 'attractive new investment opportunity'
After the FDA granted orphan drug designation to its Factor IX gene-editing product candidate, SB-FIX, as a treatment for hemophilia B, Wells Fargo analyst Jim Birchenough calls Sangamo BioSciences an "attractive new investment opportunity." Along with validating a commercial opportunity in hemophilia, SB-FIX could provide "even more valuable validation of targeting and coopting the albumin gene locus for gene insertion that may apply to a wide variety of genetic diseases," Birchenough tells investors in a research note. He keeps an Outperform rating on the shares.
08/04/16
JANY
08/04/16
DOWNGRADE
JANY
Neutral
Sangamo downgraded to Neutral from Buy at Janney Capital
11/01/16
WEDB
11/01/16
DOWNGRADE
WEDB
Neutral
Sangamo downgraded to Neutral from Outperform at Wedbush
10/19/16
PIPR
10/19/16
DOWNGRADE
PIPR
Neutral
Sangamo downgraded to Neutral from Overweight at Piper Jaffray
MYL Mylan
$39.05

0.47 (1.22%)

06/16/17
CANT
06/16/17
INITIATION
Target $41
CANT
Neutral
Mylan initiated with a Neutral at Cantor
Cantor Fitzgerald analyst Louise Chen started Mylan with a Neutral rating and $41 price target.
06/21/17
WELS
06/21/17
NO CHANGE
WELS
Market Perform
Wells wouldn't be surprised to see greater scrutiny on Mylan coal tax credits
After a new report from Reuters questioned the way in which Mylan uses its ownership of coal processing plants to keep its taxes low, Wells Fargo analyst David Maris said this topic has interested him for some time but his questions to management on the issue were not answered. Maris, who said he would not be surprised to see greater public scrutiny on this issue after the report, keeps a Market Perform rating on Mylan shares.
06/12/17
SBSH
06/12/17
NO CHANGE
Target $38
SBSH
Buy
Citi says CRL for Coherus not worst case scenario
Citi analyst Mohit Bansal says Coherus Biosciences' (CHRS) complete response letter for its biosimilar version of Neulasta, while "clearly a negative outcome," is not the worst case scenario since the FDA did not ask for another study. The analyst sees a one year delay, which impacts his discounted free cash flow model by $5 per share. Coherus in premarket trading is down 30%, or $6.25, to $14.40. A one year delay would mean Coherus' CHS-1701 could still be on markets at the same time as competition from Mylan (MYL) and ahead of Sandoz's approval in 2019, Bansal tells investors in a research note. The analyst has a Buy rating on Coherus with a $38 price target.
05/31/17
WELS
05/31/17
NO CHANGE
WELS
Market Perform
Pension fund campaign a short-term negative for Mylan, says Wells Fargo
Wells Fargo analyst David Maris believes the campaign by four major pension funds to oppose the re-election of six directors is short-term negative for Mylan but has the potential to be a longer term positive. The campaign may pose a distraction to management, but if successful, it could address some governance concerns regarding compensation and performance at the company, Maris tells investors in a research note. The analyst has a Market Perform rating on Mylan shares.
CYBR CyberArk
$51.00

0.56 (1.11%)

05/15/17
JMPS
05/15/17
NO CHANGE
JMPS
CyberArk, Proofpoint should gain from ransomware attack, says JMP Securities
JMP Securities analyst Erik Suppiger says that CyberArk (CYBR) and ProofPoint (PFPT) are particularly well-positioned in the wake of the recent ransomware attack. The analyst says that those companies' solutions "most acutely address ransomware attacks." He recommends buying both stocks but is more upbeat on CyberArk, as he thinks that the stock's 12% decline in the wake of its earnings creates a buying opportunity.
05/15/17
OPCO
05/15/17
NO CHANGE
OPCO
FireEye poised for increased demand after ransomware attack, says Oppenheimer
Oppenheimer analyst Shaul Eyal notes that according to media reports, a global ransomware attack was launched and infected up to 200,000 computers in at least 150 countries on Friday. The analyst believes the "biggest ransomware outbreak ever" could serve as a wake-up call for many organizations and countries delaying a review of their cybersecurity hygiene. In that regard, Eyal believes all cybersecurity vendors under his coverage, namely Check Point (CHKP), CyberArk (CYBR), Fortinet (FTNT), Imperva (IMPV), Mimecast (MIME), Palo Alto Networks (PANW), Splunk (SPLK), Symantec (SYMC), Verint (VRNT), but most notably FireEye (FEYE), are poised for increased demand, particularly in the EMEA region where the attacks were largely focused.
05/12/17
IMPC
05/12/17
DOWNGRADE
Target $55
IMPC
In-Line
CyberArk downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Michael Kim downgraded CyberArk to In-Line from Outperform and lowered his price target on the stock to $55 from $63, stating that he thinks the stock could be range-bound until it sees a stronger acceleration in license revenue and increased visibility from the company's acquisition of Conjur.
06/20/17
EVER
06/20/17
NO CHANGE
EVER
CyberArk, Imperva added to Small'Medium Ideas List at Evercore ISI
Evercore ISI analyst Ken Talanian added CyberArk (CYBR) and Imperva (IMPV) to the firm's Small/Medium Core Ideas List and dropped FireEye (FEYE) and Proofpoint (PFPT) from the list. The analyst says that CyberArk and Imperva are better positioned to benefit from the EU's General Data Protection Regulation, or GDPR, which seeks to strengthen the bloc's data security capabilities by forcing companies to meet certain standards by May 2018. The analyst says that CyberArk is well-positioned to be boosted by GDPR because of its focus on insider threats, while Imperva's focus on data security makes it "especially likely to benefit" from GDPR, according to the analyst.
ATEN A10 Networks
$8.24

0.03 (0.37%)

10/31/16
DADA
10/31/16
UPGRADE
DADA
Buy
A10 Networks upgraded on valuation at DA Davidson
As noted earlier, DA Davidson upgraded A10 Networks to Buy from Neutral. Analyst Mark Kelleher upgraded the stock based on valuation. He says that the company "remains well-positioned in its core ADC and DDoS markets" despite its September quarter revenue miss. Target $10.50.
10/31/16
DADA
10/31/16
UPGRADE
DADA
Buy
A10 Networks upgraded to Buy from Neutral at DA Davidson
10/28/16
10/28/16
DOWNGRADE

Perform
A10 Networks downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Ittai Kidron downgraded A10 Networks to Perform from Outperform following mixed Q3 results. The analyst attributes the challenges largely to bad timing and does not believe they raise any larger execution-related red flags. Nonetheless, Kidron is unsure that A10 Networks can deliver the magnitude of quarterly upside needed to move the stock materially higher, especially as it works to maintain a low level of profitability.
10/28/16
OPCO
10/28/16
DOWNGRADE
OPCO
Perform
A10 Networks downgraded to Perform from Outperform at Oppenheimer

TODAY'S FREE FLY STORIES

03:35
07/27/17
07/27
03:35
07/27/17
03:35
General news
FX Action: USD-CAD has traded yet lower »

FX Action: USD-CAD has…

02:25
07/27/17
07/27
02:25
07/27/17
02:25
General news
FX Update: The Fed's statement has put the dollar under the cosh »

FX Update: The…

01:30
07/27/17
07/27
01:30
07/27/17
01:30
General news
FX Action: USD-JPY logged a low at 110.78 »

FX Action: USD-JPY logged…

RETA

Reata Pharmaceuticals

$32.06

-0.46 (-1.41%)

22:11
07/26/17
07/26
22:11
07/26/17
22:11
Syndicate
Reata Pharmaceuticals 3.25M share Secondary priced at $31.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Jul

SNNA

Sienna Biopharmaceuticals

22:03
07/26/17
07/26
22:03
07/26/17
22:03
Syndicate
Sienna Biopharmaceuticals 4.3M share IPO priced at $15.00 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PG

Procter & Gamble

$89.30

0.16 (0.18%)

, BUD

AB InBev

$115.71

1.75 (1.54%)

20:25
07/26/17
07/26
20:25
07/26/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$89.30

0.16 (0.18%)

BUD

AB InBev

$115.71

1.75 (1.54%)

CMCSA

Comcast

$39.35

-0.4 (-1.01%)

CMCSK

Comcast

VZ

Verizon

$44.40

0.42 (0.95%)

MO

Altria Group

$71.73

-0.51 (-0.71%)

CELG

Celgene

$137.75

1.31 (0.96%)

CHTR

Charter

$348.77

0.77 (0.22%)

UPS

UPS

$112.29

-0.93 (-0.82%)

BMY

Bristol-Myers

$55.98

0.03 (0.05%)

DOW

Dow Chemical

$66.42

-0.43 (-0.64%)

COP

ConocoPhillips

$43.70

0.05 (0.11%)

RTN

Raytheon

$168.88

-0.71 (-0.42%)

ADP

ADP

$105.98

2.8 (2.71%)

JCI

Johnson Controls

$43.32

-0.86 (-1.95%)

LUV

Southwest

$59.52

0.7 (1.19%)

MCK

McKesson

$166.35

-1.28 (-0.76%)

PCG

PG&E

$67.90

0.39 (0.58%)

VLO

Valero

$67.99

-0.45 (-0.66%)

ALXN

Alexion

$131.07

1.72 (1.33%)

ZBH

Zimmer Biomet

$128.70

-0.07 (-0.05%)

MGM

MGM Resorts

$33.87

-0.4 (-1.17%)

DPS

Dr Pepper Snapple

$92.15

0.26 (0.28%)

KKR

KKR

$19.31

-0.15 (-0.77%)

TWTR

Twitter

$19.61

-0.36 (-1.80%)

LLL

L3 Technologies

$175.52

-1.79 (-1.01%)

NLSN

Nielsen

$39.89

1.27 (3.29%)

DNKN

Dunkin' Brands

$52.52

-0.71 (-1.33%)

WIX

Wix.com

$76.85

0.9 (1.19%)

TREE

LendingTree

$183.80

-2.25 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Aug

  • 14

    Aug

  • 21

    Aug

  • 29

    Aug

  • 30

    Aug

  • 11

    Sep

  • 13

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 23

    Oct

  • 09

    Nov

  • 05

    Mar

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:33
07/26/17
07/26
19:33
07/26/17
19:33
Periodicals
Discovery in lead to buy Scripps, Reuters says »

Discovery (DISCA) has…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

VIA

Viacom

$39.75

-0.6 (-1.49%)

, VIAB

Viacom

$34.37

-0.64 (-1.83%)

19:30
07/26/17
07/26
19:30
07/26/17
19:30
Periodicals
Breaking Periodicals news story on Viacom, Viacom »

Viacom drops bidding for…

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:28
07/26/17
07/26
19:28
07/26/17
19:28
Periodicals
Discovery offer for Scripps deemed superior to Viacom's, CNBC's Faber says »

Scripps (SNI) will enter…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

CRAY

Cray

$18.60

-0.3 (-1.59%)

, STX

Seagate

$32.34

-0.86 (-2.59%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Hot Stocks
Cray, Seagate enter partnership centered around ClusterStor »

Cray (CRAY) announced it…

CRAY

Cray

$18.60

-0.3 (-1.59%)

STX

Seagate

$32.34

-0.86 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Earnings
MiMedx backs FY17 adjusted EPS view of 31c-33c, consensus 30c »

Raises FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:17
07/26/17
07/26
19:17
07/26/17
19:17
Earnings
Breaking Earnings news story on MiMedx »

MiMedx sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:16
07/26/17
07/26
19:16
07/26/17
19:16
Earnings
MiMedx reports Q2 EPS 7c, consensus 7c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$25.59

0.15 (0.59%)

, AEP

American Electric

$69.45

0.61 (0.89%)

19:08
07/26/17
07/26
19:08
07/26/17
19:08
Hot Stocks
Invenergy, GE to build 2,000 megawatt wind farm in Oklahoma »

Invenergy, along with GE…

GE

General Electric

$25.59

0.15 (0.59%)

AEP

American Electric

$69.45

0.61 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Oct

PSA

Public Storage

$210.06

2.34 (1.13%)

19:05
07/26/17
07/26
19:05
07/26/17
19:05
Earnings
Pure Storage reports Q2 core FFO $2.51, consensus $2.54 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

, BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

18:57
07/26/17
07/26
18:57
07/26/17
18:57
Periodicals
Breaking Periodicals news story on Berkshire Hathaway, Berkshire Hathaway »

Elliott wins short delay…

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

18:43
07/26/17
07/26
18:43
07/26/17
18:43
Earnings
AXT, Inc. sees Q3 EPS 8c-10c, consensus 7c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

NGD

New Gold

$3.17

0.15 (4.97%)

18:42
07/26/17
07/26
18:42
07/26/17
18:42
Hot Stocks
New Gold names Paula Myson as CFO »

Myson has over 25 years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NGD

New Gold

$3.17

0.15 (4.97%)

18:40
07/26/17
07/26
18:40
07/26/17
18:40
Earnings
New Gold reports Q2 adjusted EPS 2c, consensus 2c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:37
07/26/17
07/26
18:37
07/26/17
18:37
Earnings
Packaging Corp. sees Q3 EPS $1.68, consensus $1.66 »

Looking ahead to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:36
07/26/17
07/26
18:36
07/26/17
18:36
Earnings
Packaging Corp. reports Q2 adjusted EPS $1.52, consensus $1.47 »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

CUBI

Customers Bancorp

$28.24

-0.25 (-0.88%)

18:31
07/26/17
07/26
18:31
07/26/17
18:31
Hot Stocks
Customers Bank expands private, commercial banking unit into Chicago »

Customers Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

HNHPF

Hon Hai Precision

$7.70

-0.02 (-0.26%)

18:21
07/26/17
07/26
18:21
07/26/17
18:21
Hot Stocks
White House welcomes Foxconn announcement of LCD panel plant in Wisconsin »

President Donald J. Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFBK

Northfield Bancorp

$16.69

-0.34 (-2.00%)

18:15
07/26/17
07/26
18:15
07/26/17
18:15
Earnings
Northfield Bancorp reports Q2 EPS 18c, consensus 16c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TXN

Texas Instruments

$82.53

1.14 (1.40%)

18:10
07/26/17
07/26
18:10
07/26/17
18:10
Periodicals
Texas Instruments' strong results, outlook signal further upside, Barron's says »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.